Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FHP6Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,443
Award facts
- Contract value 100% obligated
- $13,442.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,442.86 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) under a firm fixed-price contract type. The award, executed on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a non-set-aside competitive procurement with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills critical medical supply needs for federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a diverse range of pharmaceutical products, from brand-name medications to generics, vaccines, and specialized medical supplies across multiple therapeutic domains. XELJANZ XR is a rheumatoid arthritis treatment, reflecting the breadth of specialty pharmaceuticals the company delivers to support military and veteran healthcare programs worldwide under the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FHP6Q?
SPE2DR26FHP6Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FHP6Q worth?
The government has obligated $13,443 on SPE2DR26FHP6Q.
Is contract SPE2DR26FHP6Q an order under another contract?
Yes. SPE2DR26FHP6Q is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHP6Q competed?
The extent of competition for SPE2DR26FHP6Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award